Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma
Background Fructose 1,6-bisphosphatase 1 (FBP1) has been considered as a potential prognostic biomarker in glioblastoma (GBM), and this study explored the underlying mechanism. Methods The expression and effect of FBP1 expression on the prognosis of GBM patients were examined applying bioinformatics...
Saved in:
Main Authors: | Weihong Lu, Guozheng Huang, Yihan Yu, Xia Zhai, Xiangfeng Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2025-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/18926.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis
by: Tao Huang, et al.
Published: (2025-02-01) -
Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics
by: Li Ting-Ting, et al.
Published: (2015-06-01) -
Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis
by: Mengling Wang, et al.
Published: (2022-01-01) -
LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis
by: Zhenxiang Zhao, et al.
Published: (2025-02-01) -
Exosomal miR-21-5p from glioma associated mesenchymal stem cells promotes the progression and glycolysis of glioblastoma via PDHA1
by: Yanbin Zhang, et al.
Published: (2025-01-01)